2017 annual financial data
Cogent Biosciences, Inc. 2017 Operating margin
Cogent Biosciences, Inc. 2017 operating margin with verified reported values.
Direct answer
Operating margin was -312.82%.
Operating income was -26,152,000 USD and net income was -25,492,000 USD.
Operating cash flow was -25,835,000 USD.
Get free Cogent Biosciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,360,000 USD
- Operating income
- -26,152,000 USD
- Net income
- -25,492,000 USD
- Operating cash flow
- -25,835,000 USD